Besides, miR-302 increases the cisplatin sensitivity of ovarian cancer cells by inhibiting ATAD2 to hinder the invasiveness and EMT in cisplatin-resistant cells 44. The gene discussed is ATAD2; the disease is ovarian carcinoma.